Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Trivetrin 200 mg Solution is a Health Canada–registered veterinary drug (DIN 02145995) held by Intervet Canada Corp, containing Sulfadoxine. Health Canada lists its status as Cancelled Post Market (status date 02 Feb 2021). Nexara Health has matched 1 registration of Sulfadoxine across 1 other regulated market.

Health Canada registration

DIN02145995
Brand nameTrivetrin
Active ingredientSulfadoxine
Strength200 mg
Dosage formSolution
RouteIntramuscular ; Intravenous
CompanyIntervet Canada Corp
StatusCancelled Post Market — 02 Feb 2021
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Sulfadoxine registered in other markets

1 registration of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
United StatesSulfadoxineAnuh Pharma LimitedPowderFDA NDC

See every manufacturer of Sulfadoxine worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Trivetrin (DIN 02145995) marketed in Canada?

No. Health Canada lists DIN 02145995 as Cancelled Post Market as of 02 Feb 2021.

Who holds the Canadian licence for this product?

Intervet Canada Corp is the company of record in the Health Canada Drug Product Database.

Is Sulfadoxine registered outside Canada?

Yes — Nexara Health has matched 1 registration in 1 other market (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02145995, status date 2021-02-02; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02145995, status date 2021-02-02; national medicine registries: FDA NDC.

Health Canada Drug Product Database (DPD), DIN 02145995, status date 2021-02-02; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.